These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 803799)

  • 21. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 22. [Disopyramide in the prevention of arrhythmia following myocardial infarction and resistant arrhythmia].
    Dallocchio M; Daubeze J; Clementy J; Poisot D; Bricaud H; Broustet P
    Therapie; 1974; 29(1):119-29. PubMed ID: 4848509
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-arrhythmic action of disopyramide in comparison with that of quinidine].
    Poletti T; Aquaro G; D'Arrigo A; Pavia M
    Boll Soc Ital Cardiol; 1971; 16(9):591-600. PubMed ID: 5150385
    [No Abstract]   [Full Text] [Related]  

  • 24. [Remote results of the treatment of rhythm disturbances with disopyramide].
    Desruelles J; Gerard A
    Arch Mal Coeur Vaiss; 1970 Feb; 63(2):182-9. PubMed ID: 4191762
    [No Abstract]   [Full Text] [Related]  

  • 25. Disopyramide (Norpace) for ventricular arrhythmias.
    Med Lett Drugs Ther; 1977 Dec; 19(25):101-2. PubMed ID: 593226
    [No Abstract]   [Full Text] [Related]  

  • 26. The electrophysiology of Norpace (Part III).
    Caracta A
    Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic value of Rhytmodan in the management of ectopic arrhythmias].
    Woyda J
    Pol Tyg Lek; 1972 Dec; 27(50):1985-8. PubMed ID: 4649232
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preventive disopyramide in patients with ventricular arrhythmias detected by exercise].
    Cardonne A; Pérez-Medina T; García-Barreto D
    Arch Inst Cardiol Mex; 1976; 46(1):69-73. PubMed ID: 779692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug.
    Vismara LA; Mason DT; Amsterdam EA
    Clin Pharmacol Ther; 1974 Aug; 16(2):330-5. PubMed ID: 4851400
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of cardiac arrhythmias in the aged].
    Stazi C; Stazi F
    Clin Ter; 1989 Mar; 128(5):329-41. PubMed ID: 2470546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A seminar on Norpace (disopyramide phosphate) a new antiarrhythmic agent. Introductory remarks.
    Turiel SN; Smith WS
    Angiology; 1975 Jan; 26(1 Pt 2):65-6. PubMed ID: 1115402
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
    Smith WS
    Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.
    Zainal N; Jennings G; Jones B; Model D; Turner P; Besterman EM; Kidner PH
    J Int Med Res; 1976; 4(1 Suppl):71-3. PubMed ID: 799982
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 35. [Disopyramide: a new anti-arrhythmia drug. Clinical trials].
    Poletti T; Aquaro G; D'Arrigo A
    Minerva Med; 1970 Jun; 61(48):2678-95. PubMed ID: 5428155
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experience with disopyramide.
    Sequeira M; Luria MH
    Ohio State Med J; 1979 Feb; 75(2):67-9. PubMed ID: 424144
    [No Abstract]   [Full Text] [Related]  

  • 37. LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias.
    Storstein L
    Acta Med Scand; 1972 May; 191(5):423-8. PubMed ID: 4402323
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Decrease in auricular fibrillations by use of disopyramide. 70 trials].
    Rullière R; Vial F; Pornin M
    Nouv Presse Med; 1976 Feb; 5(9):581-2. PubMed ID: 772612
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bradycardia-tachycardia-asystole syndrome].
    Scardi S
    Minerva Med; 1973 Mar; 64(20):1050-1. PubMed ID: 4704734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.